Latest Insider Transactions at Cg Oncology, Inc. (CGON)
This section provides a real-time view of insider transactions for Cg Oncology, Inc. (CGON). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CG Oncology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CG Oncology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2024
|
Hong Fang Song |
SELL
Open market or private sale
|
Indirect |
650,455
-23.85%
|
$22,765,925
$35.36 P/Share
|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Open market or private purchase
|
Direct |
263,157
+30.0%
|
$4,999,983
$19.0 P/Share
|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Conversion of derivative security
|
Indirect |
4,941,368
+50.0%
|
-
|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Conversion of derivative security
|
Direct |
350,771
+50.0%
|
-
|
|
Jan 29
2024
|
Corleen M. Roche CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$38,000
$19.0 P/Share
|
|
Jan 29
2024
|
Vijay Kasturi Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,315
+50.0%
|
$24,985
$19.0 P/Share
|
|
Jan 29
2024
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
400,000
+50.0%
|
$7,600,000
$19.0 P/Share
|
|
Jan 29
2024
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,628,198
+44.32%
|
-
|